Table 1 General characteristics of the study population (N = 180)
From: Changes of liver enzymes and bilirubin during ischemic stroke: mechanisms and possible significance
Characteristic | Value |
|---|---|
Age (years) | 73.2 ± 13.2 |
Male sex | 85 (47.2) |
Cerebral lesion volume (ml) | 4.7 [0.4-35.5] |
Admission to emergency dept. delay (hrs)* | 1.7 [0.8-6.3] |
Admission to stroke unit delay (hrs)* | 16.8 [6–28.7] |
OCSP classification | |
LACS | 32 (17.8) |
PACS | 65 (36.1) |
TACS | 55 (30.6) |
POCS | 28 (15.6) |
TOAST classification | |
Large artery | 28 (15.6) |
Cardioembolism | 57 (31.5) |
Small artery | 45 (25.0) |
Other cause | 6 (3.3) |
Undetermined | 44 (24.4) |
Initial NIHSS score | 6 [3-15] |
<10 | 112 (62.2) |
> = 10 and < 18 | 36 (20.0) |
> = 18 | 32 (17.8) |
Diabetes | 41 (22.8) |
Hypertension | 152 (84.4) |
Current smoker | 35 (19.4) |
Ex-smoker | 31 (17.2) |
Hypercholesterolemia | 112 (62.2) |
Malignant neoplasm | 12 (6.7) |
Previous myocardial infarction | 32 (17.8) |
Previous stroke | 29 (16.1) |
Previous TIA | 9 (5.0) |
Statin (pre-admission) | 46 (25.6) |
Clopidogrel (pre-admission) | 14 (7.8) |
Oestro-progestinic (pre-admission) | 2 (1.1) |